Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Nov-Dec;36(6):437-41.
doi: 10.1016/j.bjhh.2014.07.003. Epub 2014 Jul 17.

Hemophagocytic lymphohistiocytosis: a case series of a Brazilian institution

Daniela Guimarães Rocha Ferreira  1 , Paulo do Val Rezende  1 , Mitiko Murao  1 , Marcos Borato Viana  1 , Benigna Maria de Oliveira  2
Affiliations

Hemophagocytic lymphohistiocytosis: a case series of a Brazilian institution

Daniela Guimarães Rocha Ferreira et al. Rev Bras Hematol Hemoter. 2014 Nov-Dec.

Abstract

Objective: To describe the clinical and laboratory presentation of hemophagocytic lymphohistiocytosis in children treated at a referral institution.

Methods: A retrospective descriptive study was carried out of seven children diagnosed with hemophagocytic lymphohistiocytosis between 2010 and 2012. The criteria for diagnosis were those proposed by the Histiocyte Society. When indicated, immunochemotherapy was prescribed according to the HLH94 and HLH2004 protocols of the Histiocyte Society.

Results: The patients' ages at diagnosis ranged from one month to nine years. All patients had splenomegaly, fever, anemia, thrombocytopenia, hyperferritinemia and hypertriglyceridemia. Bone marrow hemophagocytosis was detected in six patients. In six cases, infectious diseases triggered the syndrome. In two cases, associated with visceral leishmaniasis, remission was achieved after treatment of the underlying infection. Three patients, who had Epstein-Barr-related hemophagocytic lymphohistiocytosis, required treatment with immunochemotherapy. They are alive and in remission; one patient had symptoms of juvenile rheumatoid arthritis and another, who was suspected of having primary hemophagocytic lymphohistiocytosis, entered into remission after bone marrow transplantation. Two deaths (28.6%) occurred in patients with suspected primary hemophagocytic lymphohistiocytosis; one whose clinical picture was triggered by cytomegalovirus infection did not respond to immunochemotherapy and the other died before any specific treatment was provided.

Conclusion: As reported before, hemophagocytic lymphohistiocytosis has a multifaceted presentation with nonspecific signs and symptoms. In secondary forms, remission may be achieved by treating the underlying disease. In the primary forms, remission may be achieved with immunochemotherapy, but bone marrow transplantation is required for cure.

Keywords: Bone marrow transplantation; Hemophagocytic lymphohistiocytosis; Therapeutics; Visceral leishmaniasis.

PubMed Disclaimer

References

    1. Risma K., Jordan M.B. Hemophagocytic lymphohistiocytosis: updates and evolving concepts. Curr Opin Pediatr. 2012;24(1):9–15. - PubMed
    1. Henter J.I., Horne A., Aricó M., Egeler R.M., Filipovich A.H., Imashuku S. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007;48(2):124–131. - PubMed
    1. Janka G.E. Familial and acquired hemophagocytic lymphohistiocytosis. Annu Rev Med. 2012;63:233–246. - PubMed
    1. Freeman H.R., Ramanan A.V. Review of haemophagocytic lymphohistiocytosis. Arch Dis Child. 2011;96(7):688–693. - PubMed
    1. Filipovich A.H. Hemophagocytic lymphohistiocytosis (HLH) and related disorders. Hematol Am Soc Hematol Educ Program. 2009:127–131. - PubMed

LinkOut - more resources